Early Life
Albert Boehringer's family founded Boehringer Ingelheim in 1885 in Ingelheim am Rhein, Germany. The company started as a small chemical factory. The Boehringer family's entrepreneurial spirit dates back to 1817, when his great-grandfather founded a company in Stuttgart. The company later became known as C.H. Boehringer Sohn (CHBS).
Rise to Success
Boehringer Ingelheim's success is rooted in its long-term vision and commitment to research and development. The company expanded into pharmaceuticals and became one of the largest private pharmaceutical companies in the world. Albert Boehringer and his family members have been instrumental in the company's growth, overseeing a global enterprise with over 54,000 employees across 130 markets. The company's early innovations, like the mass production of lactic acid through bacteria, set the stage for their future achievements. Today, the Boehringer and von Baumbach families jointly own and manage the company.
Key Business Strategies
Boehringer Ingelheim's strategy focuses on long-term sustainability through sound financing and organic corporate growth. This includes significant investments in research and development, with approximately EUR 6.2 billion invested in 2024 alone. The company's key areas of interest include respiratory diseases, metabolism, immunology, oncology, and animal health. They have a strong emphasis on employee satisfaction and well-being.
Philanthropy
Boehringer Ingelheim is committed to improving both human and animal health, they plan on investing approximately $20 billion between 2025 and 2030 in its human and animal health business in the U.S., with a focus on R&D and manufacturing capabilities.
